Login
Home
Charts
Search
Watchlist
Products

Marico Ltd

MARICO·NSE
830.00+0.68%Tue, 22 Sept '26

Marico Ltd

MARICO
NSE
830.00
+0.68%
|Tue, 22 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
1,07,916Cr
Close
Close Price
830.00
Industry
Industry
FMCG - Personal Care
PE
Price To Earnings
56.89
PS
Price To Sales
7.56
Revenue
Revenue
14,277Cr
Rev Gr TTM
Revenue Growth TTM
25.14%
PAT Gr TTM
PAT Growth TTM
15.03%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
2,4762,4222,2782,6432,6642,7942,7303,2213,4823,5373,3013,957
Growth YoY
Revenue Growth YoY%
-0.8-1.91.76.77.615.419.821.930.726.620.922.9
Expenses
ExpensesCr
1,9791,9091,8362,0172,1422,2612,2722,5662,9222,9452,7803,138
Operating Profit
Operating ProfitCr
497513442626522533458655560592521819
OPM
OPM%
20.121.219.423.719.619.116.820.316.116.715.820.7
Other Income
Other IncomeCr
384315378242475649396048
Interest Expense
Interest ExpenseCr
201917171113121012141721
Depreciation
DepreciationCr
394241414144524547506056
PBT
PBTCr
476495399605552518441656550567504790
Tax
TaxCr
116109791311191129614311810796138
PAT
PATCr
360386320474433406345513432460408652
Growth YoY
PAT Growth YoY%
17.315.94.98.720.35.27.88.2-0.213.318.327.1
NPM
NPM%
14.515.914.117.916.314.512.615.912.413.012.416.5
EPS
EPS
2.73.02.53.63.33.12.63.93.23.53.04.9
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
2,4762,4222,2782,6432,6642,7942,7303,2213,4823,5373,3013,957
Growth YoY
Revenue Growth YoY%
-0.8-1.91.76.77.615.419.821.930.726.620.922.9
Expenses
ExpensesCr
1,9791,9091,8362,0172,1422,2612,2722,5662,9222,9452,7803,138
Operating Profit
Operating ProfitCr
497513442626522533458655560592521819
OPM
OPM%
20.121.219.423.719.619.116.820.316.116.715.820.7
Other Income
Other IncomeCr
384315378242475649396048
Interest Expense
Interest ExpenseCr
201917171113121012141721
Depreciation
DepreciationCr
394241414144524547506056
PBT
PBTCr
476495399605552518441656550567504790
Tax
TaxCr
116109791311191129614311810796138
PAT
PATCr
360386320474433406345513432460408652
Growth YoY
PAT Growth YoY%
17.315.94.98.720.35.27.88.2-0.213.318.327.1
NPM
NPM%
14.515.914.117.916.314.512.615.912.413.012.416.5
EPS
EPS
2.73.02.53.63.33.12.63.93.23.53.04.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6,0175,9186,3227,3347,3158,0489,5129,7649,65310,83113,61114,277
Growth
Revenue Growth%
5.0-1.66.816.0-0.310.018.22.6-1.112.225.725.1
Expenses
ExpensesCr
4,9664,7595,1856,0085,8466,4577,8317,9547,6278,69211,28311,785
Operating Profit
Operating ProfitCr
1,0511,1591,1371,3261,4691,5911,6811,8102,0262,1392,3282,492
OPM
OPM%
17.519.618.018.120.119.817.718.521.019.817.117.4
Other Income
Other IncomeCr
9396851029510598144142208204196
Interest Expense
Interest ExpenseCr
211716405034395673535364
Depreciation
DepreciationCr
959089131140139139155158178202213
PBT
PBTCr
1,0291,1491,1171,2571,3741,5231,6011,7431,9372,1162,2772,411
Tax
TaxCr
305338290126331324346421435458464459
PAT
PATCr
7238118271,1311,0431,1991,2551,3221,5021,6581,8131,952
Growth
PAT Growth%
23.712.12.036.8-7.815.04.75.313.610.49.315.0
NPM
NPM%
12.013.713.115.414.314.913.213.515.615.313.313.7
EPS
EPS
5.56.26.38.67.99.19.510.111.512.613.614.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6,0175,9186,3227,3347,3158,0489,5129,7649,65310,83113,61114,277
Growth
Revenue Growth%
5.0-1.66.816.0-0.310.018.22.6-1.112.225.725.1
Expenses
ExpensesCr
4,9664,7595,1856,0085,8466,4577,8317,9547,6278,69211,28311,785
Operating Profit
Operating ProfitCr
1,0511,1591,1371,3261,4691,5911,6811,8102,0262,1392,3282,492
OPM
OPM%
17.519.618.018.120.119.817.718.521.019.817.117.4
Other Income
Other IncomeCr
9396851029510598144142208204196
Interest Expense
Interest ExpenseCr
211716405034395673535364
Depreciation
DepreciationCr
959089131140139139155158178202213
PBT
PBTCr
1,0291,1491,1171,2571,3741,5231,6011,7431,9372,1162,2772,411
Tax
TaxCr
305338290126331324346421435458464459
PAT
PATCr
7238118271,1311,0431,1991,2551,3221,5021,6581,8131,952
Growth
PAT Growth%
23.712.12.036.8-7.815.04.75.313.610.49.315.0
NPM
NPM%
12.013.713.115.414.314.913.213.515.615.313.313.7
EPS
EPS
5.56.26.38.67.99.19.510.111.512.613.614.6

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
129129129129129129129129129129130
Reserves
ReservesCr
1,9572,2572,4562,8732,9213,1513,2193,6703,7033,8454,080
Current Liabilities
Current LiabilitiesCr
1,3141,2491,4581,7241,7532,0132,1532,4292,4442,4554,101
Non Current Liabilities
Non Current LiabilitiesCr
3645681981812392285618081,6111,480
Total Liabilities
Total LiabilitiesCr
3,3813,6334,0814,9094,9705,5105,7866,9467,4218,33210,075
Current Assets
Current AssetsCr
2,1072,3902,7943,2003,1493,3363,5053,8204,0035,0775,860
Non Current Assets
Non Current AssetsCr
1,2741,2431,2871,7091,8212,1742,2813,1263,4183,2554,215
Total Assets
Total AssetsCr
3,3813,6334,0814,9094,9705,5105,7866,9467,4218,33210,075
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
129129129129129129129129129129130
Reserves
ReservesCr
1,9572,2572,4562,8732,9213,1513,2193,6703,7033,8454,080
Current Liabilities
Current LiabilitiesCr
1,3141,2491,4581,7241,7532,0132,1532,4292,4442,4554,101
Non Current Liabilities
Non Current LiabilitiesCr
3645681981812392285618081,6111,480
Total Liabilities
Total LiabilitiesCr
3,3813,6334,0814,9094,9705,5105,7866,9467,4218,33210,075
Current Assets
Current AssetsCr
2,1072,3902,7943,2003,1493,3363,5053,8204,0035,0775,860
Non Current Assets
Non Current AssetsCr
1,2741,2431,2871,7091,8212,1742,2813,1263,4183,2554,215
Total Assets
Total AssetsCr
3,3813,6334,0814,9094,9705,5105,7866,9467,4218,33210,075

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
8186495161,0621,2142,0071,0161,4191,3871,3632,084
Investing Cash Flow
Investing Cash FlowCr
-197-9255-334-39-938425-865176-621-722
Financing Cash Flow
Financing Cash FlowCr
-601-574-567-698-1,147-1,058-1,290-560-1,542-649-1,279
Net Cash Flow
Net Cash FlowCr
18-518-34516153-69219383
Free Cash Flow
Free Cash FlowCr
7315673949191,0341,8708841,2371,2341,2411,772
CFO To PAT
CFO To PAT%
113.080.062.493.9116.4167.481.0107.392.382.2115.0
CFO To EBITDA
CFO To EBITDA%
77.856.045.480.182.6126.260.478.468.563.789.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
8186495161,0621,2142,0071,0161,4191,3871,3632,084
Investing Cash Flow
Investing Cash FlowCr
-197-9255-334-39-938425-865176-621-722
Financing Cash Flow
Financing Cash FlowCr
-601-574-567-698-1,147-1,058-1,290-560-1,542-649-1,279
Net Cash Flow
Net Cash FlowCr
18-518-34516153-69219383
Free Cash Flow
Free Cash FlowCr
7315673949191,0341,8708841,2371,2341,2411,772
CFO To PAT
CFO To PAT%
113.080.062.493.9116.4167.481.0107.392.382.2115.0
CFO To EBITDA
CFO To EBITDA%
77.856.045.480.182.6126.260.478.468.563.789.5

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
31,28737,98542,09544,56735,48453,13965,11162,02964,30484,39595,5761,07,916
Price To Earnings
Price To Earnings
48.551.251.740.034.845.353.047.543.351.654.356.9
Price To Sales
Price To Sales
5.26.46.15.64.46.06.25.65.86.76.17.6
Price To Book
Price To Book
15.515.916.314.811.616.219.416.316.721.122.725.6
EV To EBITDA
EV To EBITDA
29.632.837.133.524.233.138.734.231.539.441.143.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
44.147.141.940.544.042.839.742.247.747.141.441.4
OPM
OPM%
17.519.618.018.120.119.817.718.521.019.817.117.4
NPM
NPM%
12.013.713.115.414.314.913.213.515.615.313.313.7
ROCE
ROCE%
46.944.439.138.742.141.142.940.846.147.948.948.9
ROE
ROE%
34.734.032.037.734.236.537.534.839.241.743.143.1
ROA
ROA%
21.422.320.323.021.021.821.719.020.219.918.018.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
31,28737,98542,09544,56735,48453,13965,11162,02964,30484,39595,5761,07,916
Price To Earnings
Price To Earnings
48.551.251.740.034.845.353.047.543.351.654.356.9
Price To Sales
Price To Sales
5.26.46.15.64.46.06.25.65.86.76.17.6
Price To Book
Price To Book
15.515.916.314.811.616.219.416.316.721.122.725.6
EV To EBITDA
EV To EBITDA
29.632.837.133.524.233.138.734.231.539.441.143.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
44.147.141.940.544.042.839.742.247.747.141.441.4
OPM
OPM%
17.519.618.018.120.119.817.718.521.019.817.117.4
NPM
NPM%
12.013.713.115.414.314.913.213.515.615.313.313.7
ROCE
ROCE%
46.944.439.138.742.141.142.940.846.147.948.948.9
ROE
ROE%
34.734.032.037.734.236.537.534.839.241.743.143.1
ROA
ROA%
21.422.320.323.021.021.821.719.020.219.918.018.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Marico is a business built on a single, everyday ritual: nourishing hair and cooking food with coconut oil. Founded in 1988 by Harsh Mariwala, it has grown from that base into a consumer-goods house that touches one in three Indians, while steadily reshaping itself to depend less on the commodities that made it. The recurring approach is to dominate a core category with a trusted brand, use the cash and distribution muscle that dominance creates, and then bolt on younger, higher-margin businesses in foods and personal care - often by buying digital-first brands and scaling them without burning cash. # Business segments Four engines at different stages - a coconut-oil cash cow, a health-foods platform at national scale, a premium personal-care challenger built through acquisitions, and an international network that replicates the India playbook - each fed by the cash flows of the one before. ## 1. Coconut and hair oils: the franchise that funds everything else **Parachute coconut oil commands a 63% volume market share and enough pricing power to absorb 30%-plus input-cost spikes without losing volume, making it the group’s financial engine.** - **The blue-bottle moat** - Parachute Rigids, the iconic rigid-pack coconut oil, gained roughly 70 basis points of volume market share in a single year, and the broader franchise holds about 63% of the branded market even though roughly 30% of the category is still unbranded loose oil. - **Raw-material edge over smaller rivals** - copra (dried coconut kernel) makes up half the company’s raw-material basket, and Marico runs a procurement system with collection centres across Kerala, Tamil Nadu and Karnataka that buys a majority of the country’s coconuts, giving it a cost and supply-chain advantage that unbranded players cannot match. - **Farmer programmes secure the crop** - the Parachute Kalpavriksha initiative has enrolled nearly 63,000 farmers covering over 2.5 lakh acres, with more than 100 on-field agronomists helping lift farm productivity by 15%, which locks in supply at the source. - **Pricing power that protects margins** - the brand has taken price increases of more than 30% with little volume impact because coconut hair oil has low price elasticity, and the company passes on value when copra costs fall, keeping consumers from switching. - **Adjacencies extend the franchise** - the same brand name now stretches into baby care with a Virgin Coconut Oil range and, from May 26, 2026, into the ₹10,000-crore-plus shampoo market with Parachute Advansed Protein Shampoo, launched with a Re. 1 entry sachet. ## 2. Saffola foods: the health-led diversification engine **A ₹1,000-crore-plus foods business built on the Saffola master brand, anchored in oats where it is India’s number one, and amplified by a string of acquired digital-first brands that together target a ₹24,000-crore market growing at roughly 20%.** - **A health promise with no exceptions** - every Saffola product follows a “No Nasties” policy: no palm oil, no maida, no artificial colours or flavours, which gives the brand a consistent health-and-wellness identity across edible oils, oats, honey, peanut butter and ready-to-cook millets. - **Oils that do more than cook** - the four edible-oil variants (Total, Gold, Active, Tasty+) are built around patented LoSorb Technology that reduces oil absorption during frying, and Saffola Total contains Oryzanol, a compound scientifically shown to help manage cholesterol. - **A separate route to the shelf** - the Foods business runs its own go-to-market network in 3 metro cities, with dedicated salespeople focused on specialty food stores, merchandising and freshness, because oats and muesli need different shelf discipline than hair oil. - **Protein is the next frontier** - 73% of Indians are protein-deficient, and the plant-protein supplement market is approaching ₹1,000 crore, which is why Cosmix (number-one plant-protein bestseller online) and Plix sit at the centre of the next growth leg. ## 3. Premium personal care and digital-first brands: the margin-accretive challenger **A portfolio of serums, male grooming and Ayurvedic skincare that exited FY26 at an annualised run rate of over ₹1,100 crore, built on a model where acquired brands are scaled profitably rather than subsidised.** - **Beardo: the blueprint** - a digital-first beard brand acquired and turned into a full-stack male grooming label where more than two-thirds of revenue now comes from non-beard products, scaled nearly four times since FY21 and profitable at the EBITDA level. - **Just Herbs: Ayurveda meets e-commerce** - an organic-ingredient skin-and-hair-care brand that crossed ₹100 crore in revenue, sold direct-to-consumer and through online marketplaces, and was made a wholly owned subsidiary in 2024. - **Livon and Set Wet: legacy brands that stuck** - Livon, positioned as “Stylist in a Bottle,” is a ₹100-crore-plus hair-serum brand, while Set Wet leads the hair-wax category and has extended into deodorants and eau de parfum. - **No cash-burn playbook** - Beardo and Plix are already EBITDA-positive; Just Herbs and True Elements are run for sustainable 20-25% growth with a target of breakeven within 18-24 months, and 100% of advertising spend for these brands goes to digital media. - **A clinic brand without the clinics** - since mid-2024, Marico has exclusively handled sales and marketing for Kaya’s range of 75-plus dermatologist-backed personal-care products outside Kaya’s own clinics, adding a science-led skincare layer to the portfolio. ## 4. International business: the India playbook, exported **A 25%-plus contributor to group revenue, built by taking the coconut-oil core into emerging markets and then layering on premium beauty and personal-care categories through local acquisitions.** - **Bangladesh is the anchor** - the largest international market, contributing roughly 44-51% of the international business, where the non-coconut-oil portfolio has doubled its revenue share from under 20% to nearly 40% over seven years by adding baby care, shampoos and male grooming. - **Vietnam: bought into beauty** - the acquisition of Beauty X (female personal care) in 2023 and entry into a definitive agreement to acquire Skinetiq (the science-backed brand Candid, plus exclusive rights to luxury clinical brand Murad) in 2026 has turned Vietnam into a home-and-personal-care growth engine where 60% of Candid’s sales come from e-commerce. - **MENA and South Africa are the long tail** - the Middle East and North Africa contribute about 15% of the international business, while South Africa contributes roughly 8%, with brands like Fiancée in Egypt and Isoplus in the ethnic-haircare market. - **Asset-light, model-heavy** - the strategy is to enter high-growth emerging markets early, replicate the distribution-led model that worked in Bangladesh, and premiumise the mix toward premium portfolios like shampoos, skincare, hair styling care and baby care, which now account for roughly 29% of international revenue. # Distribution and go-to-market engine **A network reaching 5.8 million retail outlets and 60,000 villages, now being rewired through a three-year project to deepen direct reach from one million to 1.5 million outlets - because in Indian consumer goods, the shelf is the moat.** - **General Trade is the backbone** - the traditional corner-shop channel is seen as a long-term competitive advantage for large organised players, and Marico is investing ₹80-100 crore through Project SETU to tighten its direct-distribution grip, funded by efficiency gains elsewhere. - **Sales 3.0: micro-market control** - the sales structure has been reorganised from four geographic divisions into seven clusters defined by consumer behaviour, so that decisions on pricing and assortment can be made closer to the ground. - **A separate lane for foods** - the dedicated Foods go-to-market was launched in 3 metro cities with its own feet on street, because getting a new muesli or peanut butter onto the right shelf requires different muscle than restocking Parachute. # Group structure and partners **A listed Indian parent that has assembled its new-age portfolio through a series of staged acquisitions, each with a path to full ownership, while running international markets through local subsidiaries.** - Marico Limited is the listed entity, incorporated in October 1988 and headquartered in Mumbai. - The international business operates through Marico Bangladesh Limited (a material subsidiary), Marico South East Asia Corporation in Vietnam (which absorbed the Beauty X acquisition in 2025 and the Skinetiq acquisition in 2026), and Marico South Africa. - A collaboration with Kaya Limited gives Marico exclusive sales and marketing rights for Kaya’s 75-plus science-based personal-care products outside Kaya’s own clinics.

Documents — Marico Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/1wyingb9irq1jvpjp1j8kiin.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/ixji5i1gkxul4dzeoyudibla.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/a93hams8eg0y7mau1wjr9ze4.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/tjb6sfihbs652qo5u7u5575i.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/pj7dbmzywxbxiphx4wcf21ry.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/f30pzdb2jwxv8evsnop1i11v.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/qzpqg71qtrz5modhi5ju1si7.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/8jhg68yoyawv8l2wiqx15t3j.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/o93zkjg6ewsjkxuq1eo5w4pu.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/w08c34ynorxk6ofkgp8pig5l.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/42vympepfzikvrst9g3ev9cb.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/4oswxlc5d2oe4xm71s1ti9cf.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/sfa0xhmls5r8v5aiux3k6znu.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/iu54q2fsbntjeqciwinccdly.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/t53dpt3qc150opn522nyiqb8.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/z4e9tqmnqr5c01olbksb9dn3.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/ctf0pobnae8tg302ykhiiqos.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/d9gxddpxbzm63yed1tcu97pp.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/8a40fbyjm7ql5ou2e1lpn84y.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/xqwzts3d1lwcuamctq3b3r36.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/suvriefq2t6sz5atjtbwqw9t.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/xl2krxva6rb35yswcpgjatnw.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/j809jnyx3e00rp44anoq4i6m.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/ajaz0qpg1y50yx1vccucn1vi.pdf

Concall Transcript Summaries — Marico Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AMARICO/transcript-notes/202606/1wyingb9irq1jvpjp1j8kiin.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AMARICO/transcript-notes/202603/ixji5i1gkxul4dzeoyudibla.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AMARICO/transcript-notes/202512/a93hams8eg0y7mau1wjr9ze4.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AMARICO/transcript-notes/202509/tjb6sfihbs652qo5u7u5575i.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3AMARICO/transcript-notes/202506/pj7dbmzywxbxiphx4wcf21ry.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AMARICO/transcript-notes/202503/f30pzdb2jwxv8evsnop1i11v.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3AMARICO/transcript-notes/202412/qzpqg71qtrz5modhi5ju1si7.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AMARICO/transcript-notes/202409/8jhg68yoyawv8l2wiqx15t3j.pdf